ea0081ep841 | Pituitary and Neuroendocrinology | ECE2022
Carlos Percovich Hualpa Juan
, Anez Roberto
, Centeno Rogelio Garci a
, Fernandez Laura Gonzalez
, Munoz Diego
, Montenegro Alejandra Maricel Rivas
, Fernandez Fernandez Elisa
, Guerrero Crystal
, Gonzalez Albarran Olga
Background: The goals of acromegaly treatment are to achieve long-term biochemical control, control tumor size and decrease the risk of developing systemic comorbidities. Moreover, from the patientÂ’s perspective, symptoms and QoL are critical parameters of disease control and should be assessed routinely. To aid in the global clinical management of acromegaly, a holistic clinical decision support tool, the Acromegaly Disease Activity Tool (ACRODAT®) was developed.</p...